factual
Standard GBM care yields about 5 percent five-year survival
In the control arm, glioblastoma patients receiving maximal debulking surgery, radiation, and temozolomide had a five-year survival of about 5 percent, which Bill called essentially no chance of five-year survival.
factualpending
Speaker
BillEvidence Quote
“in our trial, the control group who received the therapy, I just described had a five year survival of about five percent”
Created: 11/19/2026, 2:27:17 AM
Your notes
Loading notes...